Distribution of intraretinal exudates in diabetic macular edema during anti-vascular endothelial growth factor therapy observed by spectral domain optical coherence tomography and fundus photography

Retina

Volumn 34, Issue 12, 2014, Pages 2407-2415

  Pemp, Berthold ^a   Deák, Gábor ^a   Prager, Sonja ^a   Mitsch, Christoph ^a   Lammer, Jan ^b   Schmidinger, Gerald ^a   Scholda, Christoph ^a   Schmidt Erfurth, Ursula ^a   Bolz, Matthias ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anti VEGF therapy; Diabetes mellitus; Diabetic macular edema; Hard exudates; Lipids; Microexudates; Optical coherence tomography

Indexed keywords

BEVACIZUMAB; CHOLESTEROL; HEMOGLOBIN A1C; RANIBIZUMAB; VASCULOTROPIN INHIBITOR; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ANTIANGIOGENIC THERAPY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; EYE; EYE PHOTOGRAPHY; FEMALE; FUNDUS PHOTOGRAPHY; HARD EXUDATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LASER COAGULATION; LOADING DRUG DOSE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETINA EXUDATE; RISK REDUCTION; SERUM; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; COMPLICATION; DIABETIC RETINOPATHY; EXUDATE; LIPID METABOLISM; MACULAR EDEMA; METABOLISM; OPTICAL COHERENCE TOMOGRAPHY; PHOTOGRAPHY; PHYSIOLOGY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; LASER COAGULATION; LIPID METABOLISM; MACULAR EDEMA; MALE; MIDDLE AGED; PHOTOGRAPHY; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84916636391     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000250     Document Type: Article

References (24)

1. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XV. The longterm incidence of macular edema. Ophthalmology 1995;102: 7-16.
2. Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009;54:1-32.
3. Bolz M, Schmidt-Erfurth U, Deak G, et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology 2009; 116:914-920.
4. Ota M, Nishijima K, Sakamoto A, et al. Optical coherence tomographic evaluation of foveal hard exudates in patients with diabetic maculopathy accompanying macular detachment. Ophthalmology 2010;117:1996-2002.
5. Deák GG, Bolz M, Kriechbaum K, et al. Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by spectral domain optical coherence tomography. Ophthalmology 2010;117:773-779.
6. Rajendram R, Fraser-Bell S, Kaines A, et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol 2012;130:972-979.
7. Do DV, Nguyen QD, Khwaja AA, et al. Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol 2013;131:139-145.
8. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie house classification. ETDRS report number 10. Ophthalmology 1991;98: S786-S806.
9. Hommel G. A stagewise rejective multiple test procedure based on a modified Bonferroni test. Biometrika 1988;75: 383-386.
10. Roider J, Liew SH, Klatt C, et al. Selective retina therapy (SRT) for clinically significant diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 2010;248:1263-1272.
11. Holm K, Ponjavic V, Lövestam-Adrian M. Using multifocal electroretinography hard exudates affect macular function in eyes with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010;248:1241-1247.
12. Soliman W, Hasler P, Sander B, Larsen M. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema. Acta Ophthalmol 2012;90:248-253.
13. Fong DS, Segal PP, Myers F, et al. Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Arch Ophthalmol 1997;115:873-877.
14. Sander B, Thornit DN, Colmorn L, et al. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter. Invest Ophthalmol Vis Sci 2007;48:3983-3987.
15. Marmor MF. Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol 1999;97:239-249.
16. SolimanW, Sander B, Jørgensen TM. Enhanced optical coherence patterns of diabetic macular oedema and their correlation with the pathophysiology. Acta Ophthalmol Scand 2007;85:613-617.
17. Nguyen QD, Tatlipinar S, Shah SM, et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 2006;142:961-969.
18. Do DV, Shah SM, Sung JU, et al. Persistent diabetic macular edema is associated with elevated hemoglobin A1c. Am J Ophthalmol 2005;139:620-623.
19. Chew EY, Klein ML, Ferris FL 3rd, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol 1996;114:1079-1084.
20. Lyons TJ, Jenkins AJ, Zheng D, et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 2004;45:910-918.
21. Miljanovic B, Glynn RJ, Nathan DM, et al. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 2004;53:2883-2892.
22. Kameda Y, Kumakawa M, Endo N, et al. Association of systemic health and functional outcomes with changes in hard exudates associated with clinically significant macular oedema over the natural course of the disease. Br J Ophthalmol 2010;94:725-729.
23. Gupta A, Gupta V, Thapar S, Bhansali A. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol 2004;137:675-682.
24. Pircher M, Hitzenberger CK, Schmidt-Erfurth U. Polarization sensitive optical coherence tomography in the human eye. Prog Retin Eye Res 2011;30:431-451.